While dealing with patients and educating them about cancer clinical trials is continually uplifting for us and for patients, spouses/families, and caregivers—especially when an advanced patient achieves life extension or can be brought back from the precipice—there are still frustrating moments.
As Catalyst blog readers know, clinical trial patient recruitment remains a roadblock to trial completion. Some principal investigators and their study nurses are missing out on what should be one of the most important set of conversations that they can have—those initial pre-enrollment conversations with the patient and his or her family or caregiver which greatly impact whether the patient will ultimately sign the informed consent.
